Melior Pharmaceuticals Announces Positive Results in Phase 2B Study with Tolimidone for Type 2 Diabetes
Tolimidone treatment significantly reduced HbA1c compared to placebo Company makes strategic decision to move tolimidone into NASH development EXTON, Pa.–(BUSINESS…